SGCB and endothelial dysfunction: However, during MI, NO availability is often significantly reduced due to ischemia and endothelial dysfunction, impairing the sGC-cGMP pathway and leading to decreased cGMP production, vasoconstriction, and exacerbation of ischemic injury [15].